NL-OMON22366Not yet recruitingNot Applicable
A randomized, open label balanced two period, two-treatment, two-sequence crossover study to evaluate the effect of food on the pharmacokinetics of buspirone after a single oral administration of Lybridos in healthy female subjects
EB FSD0 sites18 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 18
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Provision of informed consent
- •2. Females between 18 and 55 years of age (both inclusive)
Exclusion Criteria
- •Cardiovascular conditions
- •1. Systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg.
Investigators
Similar Trials
Completed
Not Applicable
A randomized, open label balanced two period, two-treatment, two-sequence crossover study to evaluate the effect of food on the pharmacokinetics of sildenafil after a single oral administration of Lybrido in healthy female subjectsSexual dysfunctionproblems with sexual functioning10040480NL-OMON41076EB FlevoResearch BV18
Completed
Not Applicable
ybrido Food effect studyVoedsel effect onderzoek naar LybridoNL-OMON25592EB FSD18
Completed
Not Applicable
A randomized, open label balanced two period, two-treatment, two-sequence crossover study to evaluate the effect of food on the pharmacokinetics of buspirone after a single oral administration of Lybridos in healthy female subjectsSexual dysfunctionproblems with sexual functioning10040480NL-OMON41098EB FlevoResearch BV18
Completed
Phase 1
A clinical trial to study the pharmacokinetic comparison of two formulations for Intravenous Infusion of Paclitaxel in Indain Patients with Metastatic Breast Cancer.CTRI/2009/091/000441Intas Pharmaceuticals Limited
Not yet recruiting
Not Applicable
To estimate the bioavailability of diosmin in FLAVOSPRINT 500 PRO versus FLAVOSPRINT in healthy adult human subjects.CTRI/2017/07/008952GIELLEPI